LDT Rule, AdComm Feedback, CardioMEMS Coverage, and Global Picks
In this week’s Pathways Picks: FDA publishes its long-awaited and, in many quarters, hated lab-developed test rule; the US agency seeks feedback on advisory committees; CMS opens CardioMEMS coverage analysis, China summarizes typical violations; and digital and data news from Europe.